Indian startup develops affordable & dual powered defibrillator, SanMitra 1000 HCT

The device can be used even in areas without electricity and does not require any battery change. It can even prove fruitful in treating COVID-19 patients suffering from issues related to rate or rhythm of the heartbeat

0
49
Image for representational purpose only!
New Delhi: Biotechnology Industry Research Assistance Council (BIRAC)-funded startup, Jeevtronics has developed SanMitra 1000 HCT, the hand-cranked dual powered defibrillator. The affordable, low-weight device is considered more reliable than traditional defibrillators by experts as it can be used even in the areas where electricity is unavailable.
The device works with both AC mains and a hand-cranked generator built into the unit, and does not require any battery change. The start-up has reported that the device’s battery has been tested for a large number of charge-discharge cycles thereby making it cost-effective. The device is ideal for hospitals located in cities and remote areas. So far, over 200 devices have been deployed across India and Africa, as per the stats provided by the start-up.
Jeevtronics, an ISO13485 certified company, has already received four patents in US and India, and had been facilitated financially by BIRAC under the schemes of BIG and IIPME (Early Transition stage) in the past. SanMitra 1000 HCT is designed to international IEC standards for medical devices and the patented technology costs INR 99,999+ taxes, which is1/4th of the big brands, as reported by the start-up. These defibrillators can be usually preferred over chest compressions (CPR), and can even prove fruitful in treating COVID-19 patients suffering from issues related to rate or rhythm of the heartbeat (Arrythmias).
As per the start-up, they have also developed the only Make-In-India “ambulance grade” defibrillator, named as Jeevtronics SanMitra 1000 HCT EMS, which has been tested at ARAI and will be priced at fraction of the cost of MNC brands.